INTRODUCTION
Diversification of T and B lymphocyte antigen receptors is fundamental to immunity. In the case of B cell antigen receptors (BCRs), clonal diversification of the antigen-combining sites occurs in two phases. The first takes place during early B cell development when unique combinations of V, (D), and J DNA segments are assembled to form the immunoglobulin (Ig) heavy and light chain variable region genes. The products of these genes combine to define the distinct antigen-binding capabilities of the BCRs expressed on each cell within the primary B cell repertoire. Depending on their BCR binding-specificity, naive B cells may recognize and be activated by structures associated with foreign cells or molecules. Collaboration with antigen-activated CD4 + T helper (Th) cells follows, leading to the proliferative expansion of activated B cells followed by their differentiation into either terminally differentiated antibody-secreting plasma cells or germinal center (GC) B cells (Goodnow et al., 2010; MacLennan, 1994 MacLennan, , 2003 . GCs are areas of intense B cell proliferation that form around the follicular dendritic cell (FDC) networks within the follicles of secondary lymphoid tissues and also contain specialized T follicular helper (Tfh) cells (Allen and Cyster, 2008; King et al., 2008) . It is typically within GCs that the second phase of BCR diversification occurs via somatic hypermutation (SHM), the introduction of point mutations into the Ig heavy and light chain variable region coding exons. Rare GC B cell clones that acquire increased affinity for foreign antigen undergo positive selection, whereby they preferentially survive, proliferate, and ultimately undergo plasma cell differentiation. This process of ''affinity maturation'' is driven by competition between GC B cells for foreign antigen presented in immune complexes on the FDC surface and the subsequent delivery of cognate help from T FH cells (Allen and Cyster, 2008; Goodnow et al., 2010; Tarlinton, 2008; Victora et al., 2010) . Thus the secondary diversification of BCRs coupled with affinity maturation in GCs provides the high-affinity serum antibodies that mediate long-term humoral immunity and form the basis of most successful vaccines (Plotkin et al., 2008) .
The essentially random nature of the genetic mechanisms responsible for generating antigen receptor diversity means that the production of lymphocyte clones capable of recognizing components of host tissues (i.e., self-antigens) is inevitable. Indeed, up to 75% of newly generated bone marrow B cells express BCRs that bind to self-antigens (Wardemann et al., 2003) . In order to benefit from lymphocyte diversity, therefore, the immune system has evolved a parallel series of ''self-tolerance'' mechanisms through which the participation of self-reactive lymphocytes in destructive autoimmune responses is largely prevented. In the case of the primary B cell repertoire, the selftolerance mechanisms responsible for eliminating, editing, or silencing self-reactive B cells have been extensively characterized (Goodnow, 1992; Nemazee, 1993; Nossal, 1994) . This has been achieved largely through the application of genetically modified mouse models that have allowed BCR specificities within the primary repertoire to be directed toward a natural or transgene-encoded self-antigen. By contrast, the dynamic and complex nature of GCs has so far thwarted attempts to identify and study self-reactive B cells generated during the formation of the secondary repertoire by SHM. This has greatly limited insights into how self-tolerance is enforced in the GC and how residual self-reactive GC B cells may contribute to autoimmunity.
The potential for B cells to acquire self-reactivity via SHM has been verified both in vitro (Casson and Manser, 1995; Diamond and Scharff, 1984) and in vivo (Olee et al., 1992; Shlomchik et al., 1990; Shlomchik et al., 1987; Tiller et al., 2007) . The demonstration that somatically mutated, pathogenic autoantibodies can emerge from the GC indicates that self-tolerance within the secondary B cell repertoire is not absolute. Nevertheless, several studies suggest that self-reactive GC B cells may be eliminated following interaction with self-antigen. These include experiments in which the injection of a bolus of exogenous antigen has resulted in widespread apoptosis of antigen-specific GC B cells (Han et al., 1995; Pulendran et al., 1995; Shokat and Goodnow, 1995) and a model in which class-switched IgG2a + B cells are eliminated by a transgenically encoded anti-IgG2a ''superantigen'' (Aït-Azzouzene et al., 2010) . Evidence also exists that naive B cells that have some self-reactivity can emerge from the GC having lost self-reactivity as a result of SHM (Casson and Manser, 1995; Guay et al., 2004; Notidis et al., 2002) . Although it would appear that self-reactive GC B cells may be inactivated under some circumstances, the current absence of a model with which to identify bona fide self-reactive B cells generated within the GC has made it difficult to determine how these cells are inactivated and under what circumstances this does or does not occur.
Here we have described a new experimental model that allows the precise identification and analysis of B cells acquiring self-reactivity in the GC. In particular, this model examines those GC B cells that represent the greatest autoimmune threat; that is, the self-reactive clones that acquire selfreactivity via SHM but retain the potential to undergo positive selection by foreign antigen. Selection against such self-reactive clones was found to occur but to be critically dependent on the concentration and location of self-antigen expression. Moreover, the data indicate that competition for self versus foreign antigen in the GC microenvironment is fundamental in determining the fate of self-reactive specificities generated by SHM.
RESULTS
A Model for Investigating Self-Reactive GC B Cells: HEL 3X and HEL 4X as Homologous Foreign and Self-Antigens The first requirement for an experimental model to identify and study self-reactive GC B cells was a population of B cells that possessed a defined and well-characterized BCR specificity. In addition, a pair of homologous foreign and self antigens were required such that: (1) the foreign but not the self-antigen binds to the BCR (i.e., naive B cells are not self-reactive) and (2) somatically mutated GC B cells gaining increased affinity for the foreign-antigen also acquire cross-reactivity with the self-antigen (see Figure S1A available online).
As a basis for this model, B cells derived from the SW HEL line of Ig transgenic mice were utilized. B cells from SW HEL mice express BCRs with the specificity of the HyHEL10 monoclonal antibody and thus bind to the foreign protein hen-egg lysozyme (HEL) with high affinity (Padlan et al., 1989; Phan et al., 2003) . Because the VDJ exon of HyHEL10 is targeted to the endogenous Ig heavy chain locus, anti-HEL SW HEL B cells undergo normal Ig class switching and SHM . To facilitate studies of affinity maturation using SW HEL B cells, we previously developed HEL 3X , a recombinant form of HEL with three amino-acid substitutions in the HyHEL10 binding site ( Figure 1A ). Figure 1E ). This response includes the formation of GCs by donor SW HEL B cells in which somatically mutated, high-affinity, anti-HEL 3X clones accumulate due to positive selection . The great majority of these affinity-matured SW HEL GC B cells carry a canonical Y53D substitution in the Ig heavy chain variable region, which results in a >100-fold increase in the affinity of HyHEL10 for HEL 3X ) driven by a ubiquitously expressed promoter (UBC) and introduced as a single copy into the ROSA26 locus (Figure 2A ; Figure S2 ). Two separate lines of mice were derived in which a polyadenylation site flanked by loxP recombination sequences was either present or absent from between the promoter and cDNA sequences (Figure 2A ). In mice lacking the polyadenylation site (mHEL 4X Tg mice), mHEL 4X self-antigen was expressed in all tissues examined ( Figure 2B ). Flow cytometric analysis demonstrated the presence of mHEL 4X on all tested hematopoietic cell types from mHEL 4X Tg mice ( Figure 2C ). Immunofluorescence histology also indicated that mHEL 4X self-antigen was expressed throughout the spleens of these mice, including in GCs ( Figure 2D ). ients revealed that clones with increased affinity for HEL 3X accumulated between days 5 and 14 of the response ( Figure 3A was apparent in mHEL 4X Tg recipients ( Figure 3C ). In contrast to WT recipients, however, development of cross-reactivity with HEL 4X was absent ( Figure 3D ). with mHEL 4X self-antigen were apparently prevented from undergoing positive selection. Immunohistology analysis confirmed that the selection of GC phenotype B cells occurred within GC structures in spleens from both recipient genotypes ( Figure S3 ).
To obtain a clearer picture of how mHEL 4X self-antigen expression was shaping the GC response to HEL 3X -SRBC, SHM analysis was performed by sequencing the Ig heavy chain variable region exon from single SW HEL GC B cells isolated on days 14 and 35. The most strongly selected mutations were those resulting in the Y53D and Y58F substitutions ( Figure 3E ). As expected, GC B cell clones carrying the Y53D substitution dominated in WT recipients. However, Y53D + clones were virtually absent from GC B cells in mHEL 4X Tg mice ( Figure 3E , Tables   S1 and S2 -SRBC in recipient mice, which we have shown previously to be derived exclusively from donor SW HEL B cells in this experimental system (Phan et al., 2005) , were as predicted by specificities detected in the GC. Thus, whereas antibodies binding HEL 3X foreign antigen were generated in both WT and mHEL 4X Tg recipients, large amounts of anti-HEL 4X IgG1 were only detected in WT recipients ( Figure 4C ). These data demonstrate that self-reactive anti-HEL 4X (Y53D + ) GC B cells are effectively prevented from undergoing positive selection in mHEL 4X Tg mice, despite their high-affinity cross-reactivity with HEL 3X foreign antigen (K a > 3 3 10 9 M À1 , Figure 4A ). However, clones that instead acquired increased affinity for HEL 3X foreign antigen while avoiding high-affinity cross-reactivity with HEL 4X self antigen (e.g., Y53D À ,Y58F + ) escaped negative selection, underwent normal positive selection, and contributed to an affinity-matured antibody response against the HEL 3X foreign-antigen. Tg mice had undergone positive selection for the Y53D substitution ( Figure 5C ; Figure S5 ), which bestowed strong binding to
, Figure 4A ; Figure S4 ). However, the Y58F substitution, which increased the affinity of Y53D Figure 6A ), which locate within and closely around GCs in the spleen, resulted in a virtual absence of Y53D + SW HEL B cell clones in splenic GCs ( Figure 6D ) and prevented the development of anti-HEL 4X serum antibody ( Figure 6E ). in the spleen ( Figure 6C ). By contrast, Cre-dependent expression of mHEL 4X in liver hepatocytes (Alb-cre) (Postic et al., 1999) (Figure 6B ) or the glomerular podocytes of the kidney (NPHS2-cre) (Moeller et al., 2003) and with no associated increase in splenic mHEL 4X expression ( Figure 6C ), did not affect either the accumulation of self-reactive Y53D + B cells in the GC (Figure 6D ) nor the production of anti-HEL 4X autoantibodies ( Figure 6E ).
Thus, although the specific expression of relatively low amounts of self-antigen proximal to the GC microenvironment effectively prevented the positive selection of selfreactive GC B cells, this was not true of the same self-antigen expressed at high concentrations in distal organs. Localization of self-antigen proximal to the GC is therefore crucial to preventing positive selection and autoantibody-production by cross-reactive GC B cells ( Figure S6 ). -SRBC foreign antigen resulted in a 4-fold increase in the frequency of SW HEL GC B cells carrying the Y53D substitution, such that they comprised $40% of the population by day 21 of the response (Figure 7C versus 5C) . On further analysis, the Y53D + clones in mHEL 4X Tg recipients were found to Figure S7A ). These mutations were present in 76% of the Y53D + GC B cell clones sequenced from HEL 3X -SRBC boosted mHEL
4X
Tg recipients ( Figure 7D ; Table S5 ). An additional 14% contained mutations predicted to reduce HEL 4X -binding by Y53D + HyHEL10 based on their homology with verified inactivating mutations (N94H, N94R) or nonconservative substitution of a known HEL contact residue (T30I) ( Figure 7D ; Table S5 ). Importantly, all modified Y53D + HyHEL10 molecules retained higher affinities for foreign antigen (HEL 3X ) than the original HyHEL10 SW HEL BCR ( Figure S7B ). Although we cannot exclude the possibility that mutations that were not analyzed here may impact on reactivity with HEL 3X and HEL 4X , our analysis does suggest that Y53D + GC B cells in mHEL 4X Tg mice persist if they possess additional somatic mutation(s) that (1) decrease their affinity for selfantigen (HEL 4X ) ( Figure S7A ) but (2) maintain increased affinity for foreign antigen (HEL 3X ) ( Figure S7B ).
DISCUSSION
The threat to self-tolerance posed by SHM of the Ig variable region genes in GC B cells has been recognized since the 1980s (Nossal, 1988) . However, although great progress has been made in determining the fate of self-reactive B cells produced by primary BCR diversification in the bone marrow, the dynamic and complex nature of SHM and selection within the GC has made it extremely difficult to identify and ascertain the fate of self-reactive B cells generated during this secondary phase of BCR diversification (Chan and Brink, 2012 ). The experimental model described here represents an important step forward in understanding how self-tolerance is enforced in the GC and how it may fail and give rise to autoimmunity. Thus, by challenging SW HEL B cells with HEL 3X in the context of mHEL 4X selfantigen expression, we have developed the ability to (1) identify bona fide selfreactive B cells generated by SHM in the GC and (2) examine the fate of these cells when their target self-antigen is expressed at varying concentrations and in different locations. Our major findings were that (1) selfreactive B cells can be effectively removed from the GC regardless of cross-reactivity with foreign antigen, (2) their removal depends on sufficient expression of the target self-antigen within or proximal to the GC, and (3) self-reactive GC B cells can escape deletion, undergo positive selection by foreign antigen, and initiate an autoantibody response if target self-antigen expression is low or physically separate from the GC. The most striking implication of these results is that there is no apparent mechanism in place to prevent self-reactive B cells generated in the GC from producing autoantibodies directed no Cre (n = 20), B cell Cre (n = 17), liver Cre (n = 29), kidney Cre (n = 24). SHM data comprise pooled data from two independent experiments (n = 6 per experimental group).
(E) Endpoint titer data of anti-HEL 4X IgG1 in day 21 sera. Data is representative of five independent experiments. ****p < 0.0001, **p = 0.001 to 0.01, ns = not significant.
against self-antigens expressed outside the GC microenvironment. Thus GC B cells that acquire reactivity with selfantigen expressed in a distal organ such as the liver remain susceptible to positive selection by cross-reactive foreign antigen and can therefore differentiate unimpeded into autoantibody-producing plasma cells. This failure to enforce selftolerance to tissue-specific self-antigens in GC B cells stands in contrast to the purging of B and T lymphocytes recognizing this class of self-antigen at other checkpoints during lymphocyte differentiation. In the primary B cell repertoire, for instance, B cells recognizing tissuespecific antigens circulate through the body in a quiescent state and can be deleted or rendered inactive when they encounter their cognate self-antigen (Rojas et al., 2001; Russell et al., 1991) . Furthermore, specialized medullary epithelial cells located in the thymus purge the early T cell repertoire of many clones reactive to distally expressed self-antigens by presenting peptides from these tissue-specific proteins (Mathis and Benoist, 2009) . It is likely, therefore, that the incomplete control of self-reactive B cells generated in the GC represents a ''weak link'' in the mechanisms that collectively enforce self-tolerance in the immune system. The failure to comprehensively enforce self-tolerance in the GC may be attributed to the difficulty of controlling self-reactive B cells generated in the midst of an active immune reaction against foreign antigen. Thus, in the absence of sufficient amounts of target self-antigen Immunity Self-Reactivity in the Germinal Center Reaction proximal to the GC microenvironment, self-reactive GC B cells remain ''ignorant'' of their self-reactivity and continue to receive help from GC-resident anti-foreign T FH cells. In this way, the production of antibodies against tissue-specific self-antigens can proceed without the need to compromise T cell self-tolerance. These findings imply that autoantibody production could emerge from any humoral immune response directed against a foreign antigen that has some structural homology to a tissue-specific self-antigen. Evidence that this phenomenon (Table   S5 ) as well as the Y53D + GC B cell population from WT recipient mice (Table S3 ). See Figure S7 for HEL 4X and HEL 3X binding analyses.
occurs during conventional immune responses is provided by the emergence of cross-reactive autoantibodies in response to viral antigens (Srinivasappa et al., 1986) and the frequent association of cross-reactive autoantibodies with postinfectious, tissue-specific autoimmune diseases such as hepatitis C-related immune thrombocytopenia (Zhang et al., 2009) , pauci-immune focal necrotizing glomerulonephritis (Kain et al., 2008) , Chagas disease (CunhaNeto et al., 2006) , Guillain-Barré syndrome (Yuki et al., 2004) , and rheumatic carditis (Guilherme et al., 2006) . Thus the inability of the immune system to prevent the production of cross-reactive autoantibodies from the GC response may contribute to the onset and/or progression of a number of human autoimmune diseases. One of the key implications of our findings is that the balance between the recognition of self and foreign antigens is critical to determining the fate of self-reactive GC B cells. In this regard, both the amount of each competing antigen type and the relative affinity of the BCR for them each play important roles. This point is illustrated by our finding that the reduced expression of mHEL of the higher-affinity Y53D + ,Y58F + self-reactive clones. Mechanistically, we propose that the preferential association of GC B cells with self instead of foreign antigen prevents the reception of sufficient stimulatory signals from foreign antigen and limits their access to help from GC-resident T FH cells (Victora et al., 2010) . Under such circumstances, self-reactive GC B cells would be at a competitive disadvantage compared to cells that recognize foreign but not self-antigen and so would fail to be propagated in the GC (eg Y53D + versus Y53D À ,Y58F + clones in mHEL 4X Tg mice).
Another possibility is that the interaction of GC B cells with self versus foreign antigen leads to the delivery of quantitatively or qualitatively distinct signal(s) that result in the direct killing of self-reactive GC B cells. This may be true in particular when self-antigen is present at high concentrations, because GC B cells undergo rapid cell death when exposed to very high concentrations of exogenous antigen (Han et al., 1995; Pulendran et al., 1995; Shokat and Goodnow, 1995) . In these models of GC negative selection, the death of antigen-reactive GC B cells was at least partially blocked by overexpression of the anti-apoptotic protein Bcl-2. Interestingly, this strategy reduces overall apoptosis in the GC and also blocks the death of GC B cells that would otherwise be removed due to their low affinity for foreign antigen (Smith et al., 2000) . It will be of interest to determine whether the death of bona fide self-reactive B cells will also be blocked by overexpression of Bcl-2, or whether potentially other members of the Bcl-2 family, such as Mcl-1 (Vikstrom et al., 2010) , may play a more prominent role.
Although the form of antigen used in this study provides a strong source of SRBC-specific T cell help to HEL 3X -binding SW HEL B cells, it is possible that the use of alternative adjuvants and/or sources of T cell help might provide a stronger selection for foreign antigen and thus facilitate selection of cross-reactive GC B cells even when the target self-antigen is expressed at high concentrations. Separate experiments in which HEL 3X was conjugated to ovalbumin and injected in alum adjuvant failed to rescue self-reactive SW HEL GC B cells or generate anti-HEL 4X autoantibodies in mHEL 4X Tg recipients (data not shown).
This result, together with demonstration here that boosting with HEL 3X -SRBC also fails to break self-tolerance in mHEL 4X Tg mice, indicates that the enforcement of GC self-tolerance is robust when self-antigen is expressed at sufficient concentrations proximal to the GC. Nevertheless, it will be of interest to determine whether potentially stronger challenges, such as HEL 3X conjugated with TLR ligands or active pathogens, might more readily compromise GC self-tolerance and precipitate autoimmunity. The results presented here reveal an exceptional capability for SHM-coupled positive and negative selection in the GC to shape BCR binding specificities to match the local antigen environment. While optimization of BCR affinity for foreign antigen drives the GC reaction, avoidance of cross-reactivity with localized self-antigen exerts a dominant influence that ultimately determines which somatic mutations can contribute to high affinity antibodies directed against foreign antigens. On the other hand, the failure of self-antigens expressed distal to the GC to have any impact on the secondary B cell repertoire represents an autoimmune risk. This ''weak link'' in self-tolerance is likely to contribute to the production of cross-reactive autoantibodies that can recognize tissue-specific self-antigens and potentially to the genesis of postinfectious autoimmune disease.
EXPERIMENTAL PROCEDURES HEL
3X and HEL 4X Proteins HEL 3X is a recombinant version of HEL that carries the R21Q, R73E, and D101R substitutions . To produce HEL
4X
, a pIRES expression plasmid was first produced carrying a cDNA encoding a membranebound form of HEL 3X (mHEL 3X ) with the transmembrane and cytoplasmic domains of the H-2K k class I major histocompatibility complex (MHC) molecule (Hartley et al., 1991) . Candidate mHEL 4X molecules were produced by introducing a variety of amino acid substitutions at the K97 position of and expressed separately on the surface of HEK293. The substitution chosen was K97R ( Figure 1A) . cDNAs encoding soluble, His-tagged versions of HEL
3X
and HEL 4X were cloned into the pPIC9K vector and the recombinant proteins expressed in yeast (Pichia pastoris) and purified from culture supernatants . Figure S2 ). Soluble HEL 4X is detectable in sera from mHEL 4X Tg mice (range 4-11 ng/ml in 6 mice) but is undetectable (<1 ng/ml) in straight flox-mHEL 4X Tg mice and all Cre Tg crosses.
Other Mice and SW HEL B Cell Transfer Experiments SW HEL mice (Phan et al., 2003) were bred onto a CD45.1 congenic C57BL/6 background while all other mice were maintained on a pure C57BL/6 (CD45.2 + ) background. All mice were bred and housed in specific pathogen-free conditions at Australian Bioresources (Moss Vale, Australia) and the Garvan Institute. The following Cre Tg lines were used: Cd19-cre (Rickert et al., 1997) , Alb-cre (Postic et al., 1999) , NPHS2-cre (Moeller et al., 2003) . -SRBC (2 3 10 8 per recipient) were performed as described . All animal experiments were carried out in accordance with the guidelines of the Garvan St Vincent's Animal Ethics Committee.
Flow Cytometric Analysis
Staining procedures, reagents, data acquisition, and analysis of flow cytometry data have been previously described (Chan et al., 2009 (50 ng/ml and 100 ng/ml, respectively) followed by HyHEL9-Alexa 647. Surface expression of mHEL 4X was detected directly with HyHEL9-Alexa647 and B cell, T cell, and red blood cell (RBC) subpopulations identified using the B220, CD3, and TER-119 lineage-specific markers, respectively.
